UnitedHealth's Q1 Earnings Exceed Expectations, Shares Rise

UnitedHealth Group (UNH) delivered a powerful first quarter for 2026, reporting revenue of $111.7 billion — up 2% year-over-year — and adjusted EPS of $7.23, well ahead of analyst consensus at $6.57. The medical cost ratio improved to 83.9%, reflecting more effective management of care expenses. Shares surged 9.55% on April 21 as investors rewarded the beat and raised outlook.

Management lifted full-year 2026 adjusted EPS guidance to more than $18.25 per share, up from the prior target of more than $17.75, while maintaining revenue guidance above $439 billion. The company also announced at least $2.0 billion in share repurchases through the end of Q2. Operating cash flow remained robust at $8.9 billion — approximately 1.4x net income — underscoring the quality of earnings behind the headline numbers.

The results position UnitedHealth as a relative safe haven in healthcare despite ongoing scrutiny of Medicare Advantage reimbursement rates and rising utilization trends across the sector. Investors will watch whether the improved MCR trajectory holds into Q2, as a reversal could quickly reassert pressure on the stock and reopen regulatory valuation debates that have weighed on the managed care group through much of 2025.